Moderate to severe pain research hub

First administration of a single and increasing doses of BDT272 to assess its safety and pharmacokinetic in healthy volunteers

This study is looking for healthy volunteers to test a new medicine called BDT272. It's the first time this medicine will be given to people. The main aim is to see if it's safe and how the body handles it, to help treat moderate to severe pain in the future.